Cargando…

Comparative analysis of package inserts of local and imported antihypertensive medications in Palestine

BACKGROUND: Package inserts (PIs) as a reliable reference for patients and health care providers should provide accurate, complete and up-to-date information. The purpose of the current study is to assess and compare the PIs of antihypertensive agents locally produced in Palestine and their imported...

Descripción completa

Detalles Bibliográficos
Autores principales: Qatmosh, Sandra A., Koni, Amer A., Qeeno, Baraa G., Arandy, Dina A., Abu-Hashia, Maysa W., Al-hroub, Bahaa M., Zyoud, Sa’ed H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613627/
https://www.ncbi.nlm.nih.gov/pubmed/28946858
http://dx.doi.org/10.1186/s12889-017-4782-x
_version_ 1783266298555269120
author Qatmosh, Sandra A.
Koni, Amer A.
Qeeno, Baraa G.
Arandy, Dina A.
Abu-Hashia, Maysa W.
Al-hroub, Bahaa M.
Zyoud, Sa’ed H.
author_facet Qatmosh, Sandra A.
Koni, Amer A.
Qeeno, Baraa G.
Arandy, Dina A.
Abu-Hashia, Maysa W.
Al-hroub, Bahaa M.
Zyoud, Sa’ed H.
author_sort Qatmosh, Sandra A.
collection PubMed
description BACKGROUND: Package inserts (PIs) as a reliable reference for patients and health care providers should provide accurate, complete and up-to-date information. The purpose of the current study is to assess and compare the PIs of antihypertensive agents locally produced in Palestine and their imported counterparts. METHODS: Thirty-five PIs were assessed for the presence of 31 information statements using a scoring method. Word counting of 20 headings and subheadings was used to evaluate and compare local and imported PIs for information quantity. RESULTS: None of the analysed PIs fulfilled the criteria. All of them included the brand name, active ingredients, indications, directions for use, adverse drug reactions, drug–drug interactions, pregnancy and lactation considerations, and storage. Whereas none of them, either local or imported PIs, included the shelf life and instructions to convert tablets or capsules into liquid forms. Additionally, only one (5%) imported and no (0%) local PIs mentioned the duration of therapy. Moreover, 93.4% of local PIs were deficient in areas regarding the inactive ingredients and date of last revision, and 86.7% did not mention the drug dose and possibility of tablet splitting. Furthermore, the maximum dose was not indicated in 90% of imported and 86.7% of local PIs. In general, imported PIs contained more detailed information than their local counterparts, where the range of differences in medians between the local and imported PIs was from 1.5-fold for pregnancy considerations to >42.00-fold for the effect on the ability to drive and use machines. CONCLUSIONS: The findings of this study revealed the superiority of imported over local PIs in both quality and quantity of information provided. This emphasises the need for appropriate measures to be taken by the Ministry of Health and local manufacturers to ensure efficiency of local PIs in providing accurate, complete and up-to-date information.
format Online
Article
Text
id pubmed-5613627
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56136272017-10-11 Comparative analysis of package inserts of local and imported antihypertensive medications in Palestine Qatmosh, Sandra A. Koni, Amer A. Qeeno, Baraa G. Arandy, Dina A. Abu-Hashia, Maysa W. Al-hroub, Bahaa M. Zyoud, Sa’ed H. BMC Public Health Research Article BACKGROUND: Package inserts (PIs) as a reliable reference for patients and health care providers should provide accurate, complete and up-to-date information. The purpose of the current study is to assess and compare the PIs of antihypertensive agents locally produced in Palestine and their imported counterparts. METHODS: Thirty-five PIs were assessed for the presence of 31 information statements using a scoring method. Word counting of 20 headings and subheadings was used to evaluate and compare local and imported PIs for information quantity. RESULTS: None of the analysed PIs fulfilled the criteria. All of them included the brand name, active ingredients, indications, directions for use, adverse drug reactions, drug–drug interactions, pregnancy and lactation considerations, and storage. Whereas none of them, either local or imported PIs, included the shelf life and instructions to convert tablets or capsules into liquid forms. Additionally, only one (5%) imported and no (0%) local PIs mentioned the duration of therapy. Moreover, 93.4% of local PIs were deficient in areas regarding the inactive ingredients and date of last revision, and 86.7% did not mention the drug dose and possibility of tablet splitting. Furthermore, the maximum dose was not indicated in 90% of imported and 86.7% of local PIs. In general, imported PIs contained more detailed information than their local counterparts, where the range of differences in medians between the local and imported PIs was from 1.5-fold for pregnancy considerations to >42.00-fold for the effect on the ability to drive and use machines. CONCLUSIONS: The findings of this study revealed the superiority of imported over local PIs in both quality and quantity of information provided. This emphasises the need for appropriate measures to be taken by the Ministry of Health and local manufacturers to ensure efficiency of local PIs in providing accurate, complete and up-to-date information. BioMed Central 2017-09-25 /pmc/articles/PMC5613627/ /pubmed/28946858 http://dx.doi.org/10.1186/s12889-017-4782-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Qatmosh, Sandra A.
Koni, Amer A.
Qeeno, Baraa G.
Arandy, Dina A.
Abu-Hashia, Maysa W.
Al-hroub, Bahaa M.
Zyoud, Sa’ed H.
Comparative analysis of package inserts of local and imported antihypertensive medications in Palestine
title Comparative analysis of package inserts of local and imported antihypertensive medications in Palestine
title_full Comparative analysis of package inserts of local and imported antihypertensive medications in Palestine
title_fullStr Comparative analysis of package inserts of local and imported antihypertensive medications in Palestine
title_full_unstemmed Comparative analysis of package inserts of local and imported antihypertensive medications in Palestine
title_short Comparative analysis of package inserts of local and imported antihypertensive medications in Palestine
title_sort comparative analysis of package inserts of local and imported antihypertensive medications in palestine
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613627/
https://www.ncbi.nlm.nih.gov/pubmed/28946858
http://dx.doi.org/10.1186/s12889-017-4782-x
work_keys_str_mv AT qatmoshsandraa comparativeanalysisofpackageinsertsoflocalandimportedantihypertensivemedicationsinpalestine
AT koniamera comparativeanalysisofpackageinsertsoflocalandimportedantihypertensivemedicationsinpalestine
AT qeenobaraag comparativeanalysisofpackageinsertsoflocalandimportedantihypertensivemedicationsinpalestine
AT arandydinaa comparativeanalysisofpackageinsertsoflocalandimportedantihypertensivemedicationsinpalestine
AT abuhashiamaysaw comparativeanalysisofpackageinsertsoflocalandimportedantihypertensivemedicationsinpalestine
AT alhroubbahaam comparativeanalysisofpackageinsertsoflocalandimportedantihypertensivemedicationsinpalestine
AT zyoudsaedh comparativeanalysisofpackageinsertsoflocalandimportedantihypertensivemedicationsinpalestine